Back to Awarded Treatment Trials
Awarded Trial: 01T-084
Grant ID
01T-084
Illness
Bipolar Disorder
Primary Drug/Intervention
S-Adenosyl-methionine (SAMe)
Primary Dosage
400 mg- 800 mg b.i.d.
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Terminated
Investigator
Kagan
Sample Size
10
Duration of Study Period for Each Subject
4 months
Outcome Measurements
HAM-D, Beck Depression Inventory, CARS-M
Results
Terminated due to poor enrollment.
Publication
N/A
Link
N/A
PI Name
Bruce Kagan
Degree
MD
Center
Brain Research Institute, Mental Retardation Research Center
Institution
UCLA Neuropsychiatric Institute, David Geffen School of Medicine
Address
760 Westwood Plaza
City or Town
Los Angeles
State or Province
CA
Zip or Postal Code
90024
Country
USA
Email Address
bkagan@mednet.ucla.edu